GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Short-Term Capital Lease Obligation

Achieve Life Sciences (STU:SP4P) Short-Term Capital Lease Obligation : €0.03 Mil (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Short-Term Capital Lease Obligation?

Achieve Life Sciences's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.03 Mil.

Achieve Life Sciences's quarterly Short-Term Capital Lease Obligation declined from Dec. 2023 (€0.06 Mil) to Mar. 2024 (€0.05 Mil) and declined from Mar. 2024 (€0.05 Mil) to Jun. 2024 (€0.03 Mil).

Achieve Life Sciences's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.06 Mil) but then increased from Dec. 2022 (€0.06 Mil) to Dec. 2023 (€0.06 Mil).


Achieve Life Sciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Achieve Life Sciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Short-Term Capital Lease Obligation Chart

Achieve Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.08 0.06 0.06 0.06

Achieve Life Sciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.06 0.05 0.03

Achieve Life Sciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Achieve Life Sciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Achieve Life Sciences Business Description

Industry
Traded in Other Exchanges
Address
22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences Headlines

No Headlines